Beutel, Goodman & Co Ltd.

Position in NVS — Novartis AG

CIK 1361974 TORONTO, A6

Position in NVS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,914,835

+$39,469 QoQ

Shares Held

18,599

-1.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#353

of 1,596 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Beutel, Goodman & Co Ltd. holds $470,436,702 across 7 Drug Manufacturers - General names. NVS ranks #4 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	2,073,206	$266,406,971
2	AMGN	Amgen Inc	520,577	$188,511,343
3	JNJ	Johnson & Johnson	36,671	$9,313,333
4	NVS	Novartis AG This page	18,599	$2,914,835
5	NVO	Novo Nordisk A S	55,413	$2,656,499
6	GSK	GSK plc	11,584	$607,233
7	PFE	Pfizer Inc	1,100	$26,488

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,914,835	18,599	-1.2%	Shares	Sole	2026-08-12
2026-03-31	$2,875,366	18,824	+0.9%	Shares	Sole	2026-05-15
2025-12-31	$2,571,964	18,655	+1.2%	Shares	Sole	2026-02-13
2025-09-30	$2,364,745	18,440	+52.3%	Shares	Sole	2025-11-14
2025-06-30	$1,465,431	12,110	-11.7%	Shares	Sole	2025-08-13
2025-03-31	$1,529,505	13,720	+412.9%	Shares	Sole	2025-05-14
2024-12-31	$260,304	2,675	-8.5%	Shares	Sole	2025-02-12
2024-09-30	$336,433	2,925	-33.6%	Shares	Sole	2024-11-13
2024-06-30	$468,956	4,405	0.0%	Shares	Sole	2024-08-13
2024-03-31	$426,095	4,405	+0.9%	Shares	Sole	2024-05-14
2023-12-31	$440,734	4,365	+54.0%	Shares	Sole	2024-02-09
2023-09-30	$288,773	2,835	+8.6%	Shares	Sole	2023-11-13
2023-06-30	$263,375	2,610	0.0%	Shares	Sole	2023-08-14
2023-03-31	$240,120	2,610	+4.8%	Shares	Sole	2023-05-12
2022-12-31	$225,892	2,490	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.